Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News SOPHiA GENETICS SA SOPH

Healthcare Medical Devices
Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. The Company offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The Company has offices in Switzerland, France and the United Kingdom and... see more

Recent & Breaking News (NDAQ:SOPH)

SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer

PR Newswire 1 day ago

SOPHiA GENETICS Reports Third Quarter 2024 Results

PR Newswire 1 day ago

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2024 on November 5, 2024

PR Newswire October 22, 2024

SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024

PR Newswire September 14, 2024

SOPHiA GENETICS Announces Poster Presentations at ESMO 2024

PR Newswire September 12, 2024

SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024

PR Newswire September 12, 2024

SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing

PR Newswire September 10, 2024

SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024

PR Newswire September 5, 2024

SOPHiA GENETICS Unveils New Generation of the SOPHiA DDMTM Platform at Morgan Stanley Healthcare Conference 2024

PR Newswire September 4, 2024

SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference

PR Newswire August 28, 2024

SOPHiA DDM(TM) Platform Certified Under IVDR

PR Newswire August 14, 2024

SOPHiA GENETICS Reports Second Quarter 2024 Results

PR Newswire August 6, 2024

SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM(TM)

PR Newswire July 29, 2024

SOPHiA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix

PR Newswire July 24, 2024

SOPHiA GENETICS to Announce Financial Results for Second Quarter 2024 on August 6, 2024

PR Newswire July 23, 2024

India-Based Dhiti Omics is Now Live on SOPHiA DDM(TM)

PR Newswire July 4, 2024

SOPHiA GENETICS Publishes Results of 2024 Annual General Meeting

GlobeNewswire June 24, 2024

SOPHiA GENETICS Launches New Residual Acute Myeloid (RAM) Application

PR Newswire June 24, 2024

SOPHiA GENETICS Announces Kepler Uniklinikum is Live on SOPHiA DDM(TM) Platform

PR Newswire June 13, 2024

SOPHiA GENETICS Launches Global Consortium, SOPHiA UNITY, to Accelerate Cancer Research, Drug Development, and Data-Driven Patient Care

PR Newswire May 30, 2024